So you're questioning one of the world's leading company's strategy in putting a product to market? That same company has revenue in the multi billions. Ok then.
Focus has not shifted solely to Bodyguard. Bodyguard is up to the clinical trial phase. Did you only read the title of last night's announcement?
Your post is downright annoying by complete ignorance.
Speed to Market, page-2
Add WFL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable